BackVertex Pharmaceuticals Overview
Vertex Pharmaceuticals, Inc.

Vertex Pharmaceuticals Discounted Cash Flow

DCF Analysis for VRTX.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$630.54

Current Fair Value

$630.54
39.9% Upside

Undervalued by 39.9% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading